Sakamoto Yushi, Naruo Seiichiro, Ozaki Tomonori, Tahata Shogo, Fujimoto Toru, Ogata Atushi, Yoshioka Fumitaka, Nakahara Yukiko, Masuoka Jun, Abe Tatsuya
Department of Spine Surgery, Naruo Orthopedic Hospital, Kumamoto, Japan.
Department of Neurosurgery, Faculty of Medicine, Saga University, Saga, Japan.
Asian J Neurosurg. 2024 Jun 12;19(3):478-483. doi: 10.1055/s-0044-1787777. eCollection 2024 Sep.
This study aimed to evaluate the usefulness and safety of gelatin-thrombin matrix sealants (GTMSs) in minimally invasive microscopic discectomy, a surgical procedure commonly used to treat lumbar disc herniation. Out of 484 patients who underwent minimally invasive microscopic discectomy between April 2018 and December 2022, 35 patients with a history of surgery at the same level were excluded, resulting in a total of 449 patients included in the study. Among them, 316 patients were treated using GTMS, whereas 133 were treated using collagen-based absorbable local hemostatic agents. Patient characteristics, surgical duration, intraoperative blood loss, postoperative drainage volume, intraoperative dural injury, and incidence of postoperative epidural hematoma were analyzed and compared between the two groups. No significant differences in patient demographics were observed between the two groups, except for activated partial thromboplastin time and prothrombin time. Although there were no significant differences in the mean surgical time and intraoperative blood loss between the two groups, they tended to be shorter and less in the GTMS group (56.3 ± 20.2 vs. 58.2 ± 20.4 minutes [ = 0.36] and 10.0 ± 15.4 vs. 11.8 ± 8.3 g [ = 0.20]). The volume of postoperative drainage was significantly lower in the GTMS group than that in the comparison group (35.3 ± 21.8 vs. 49.5 ± 34.1 g [ < 0.01]). There was a trend indicating a difference in the number of intraoperative dural injuries and the need for reoperation due to postoperative epidural hematoma (2 vs. 3 ± 20.4 minutes [ = 0.21] and 1 vs. 2 [ = 0.16]). The use of a GTMS in minimally invasive microscopic discectomy appears to be beneficial in reducing postoperative drainage volume. It has also been shown that it may improve clinical outcomes such as intraoperative dural injury and postoperative epidural hematoma. Furthermore, further consideration of the medical economic impact is required.
本研究旨在评估明胶-凝血酶基质封闭剂(GTMS)在微创显微椎间盘切除术中的有效性和安全性,微创显微椎间盘切除术是一种常用于治疗腰椎间盘突出症的外科手术。在2018年4月至2022年12月期间接受微创显微椎间盘切除术的484例患者中,排除了35例在同一节段有手术史的患者,最终共有449例患者纳入本研究。其中,316例患者使用GTMS治疗,而133例患者使用基于胶原蛋白的可吸收局部止血剂治疗。分析并比较了两组患者的特征、手术时间、术中失血量、术后引流量、术中硬脊膜损伤情况以及术后硬膜外血肿的发生率。除活化部分凝血活酶时间和凝血酶原时间外,两组患者的人口统计学特征无显著差异。虽然两组患者的平均手术时间和术中失血量无显著差异,但GTMS组的手术时间往往更短,失血量更少(56.3±20.2 vs. 58.2±20.4分钟[P = 0.36],10.0±15.4 vs. 11.8±8.3克[P = 0.20])。GTMS组的术后引流量明显低于对照组(35.3±21.8 vs. 49.5±34.1克[P < 0.01])。术中硬脊膜损伤的数量以及因术后硬膜外血肿而需要再次手术的情况存在差异趋势(2 vs. 3±20.4分钟[P = 0.21],1 vs. 2[P =